Over 40% of U.S. Adults With High Cholesterol Aren’t Getting Treated

High cholesterol has a talent for drama without the courtesy of a trailer. No symptoms. No warning lights. No “Check Engine” icon blinking on your forehead. And yet, it quietly helps set the stage for heart attacks and strokesoften years later, when you’d really prefer it not to.

The frustrating headline: a large national analysis found that for adults with elevated LDL (“bad”) cholesterol, a big chunk are both unaware they have it and not treated. For LDL in the 160–189 mg/dL range, the unaware-and-untreated share was still about 42.7% in the most recent survey period analyzed (2017–2020). Even among people with LDL ≥190 mg/dLwhere medication is typically strongly indicatedabout 26.8% were unaware and untreated. That’s progress compared with 1999–2000, but it’s not exactly a victory lap.

Let’s translate what this means in normal-human terms, why it happens, and what “getting treated” can look like in real lifewithout turning your dinner table into a chemistry lab or your medicine cabinet into a haunted house.

The Numbers Behind the Headline (and Why They Matter)

Researchers used decades of NHANES data (a major U.S. health survey) and focused on adults with elevated LDL: 160–189 mg/dL (“high”) and ≥190 mg/dL (“very high”). The study found that:

• The age-adjusted prevalence of LDL 160–189 mg/dL dropped from about 12.4% (1999–2000) to 6.1% (2017–2020), but millions of adults still fall in this range.
• Among adults with LDL 160–189 mg/dL, the fraction who were unaware and untreated was still ~42.7% in 2017–2020.
• Among adults with LDL ≥190 mg/dL, the fraction who were unaware and untreated was ~26.8% in 2017–2020 (roughly “one in four”).
• The “gap” was more common in younger adults, men, people without insurance, and people facing socioeconomic barriers.

Why this matters: LDL contributes to plaque buildup in arteries over time. If you don’t know your LDL, you can’t manage it. And if you’re not managing itespecially if it’s very highyou’re letting a preventable risk compound like interest. (Unfortunately, cholesterol compounds don’t come with cash-back rewards.)

What Counts as “High Cholesterol,” Exactly?

Cholesterol isn’t one number. It’s a panel. But LDL is often the star of the “please don’t be high” show. A common way to describe adult LDL ranges is:

• Optimal: under 100 mg/dL
• Near optimal: 100–129 mg/dL
• Borderline high: 130–159 mg/dL
• High: 160–189 mg/dL
• Very high: 190 mg/dL and higher

These ranges are guidelines, and personal targets depend on overall cardiovascular risk (age, blood pressure, diabetes, smoking, family history, existing heart disease, and more). But LDL ≥190 mg/dL is a major red flag because it can signal genetic risk (like familial hypercholesterolemia) and typically calls for medication in addition to lifestyle changes.

Why So Many People Don’t Get Treated

1) High cholesterol is silent (and silence is convincing)

The CDC puts it simply: high cholesterol usually has no symptoms. A blood test is the only way to know. That makes it easy to ignorebecause ignoring something you can’t feel is basically a national pastime.

2) Screening is inconsistent

Most healthy adults are generally advised to have cholesterol checked every 4 to 6 years. Many people do get screenedbut “many” isn’t “all,” and gaps are bigger when primary care access is limited, insurance is inconsistent, or life is chaotic (which, to be fair, is most of life).

3) “But I’m young” is not a cholesterol strategy

Younger adults in the study had especially high rates of being unaware and untreated. That makes sense socially (fewer doctor visits) and psychologically (“heart disease is a future-me problem”), but LDL doesn’t care about your vibe.

4) Statin fear, side-effect confusion, and the nocebo effect

Some people hear “statin” and immediately picture a villain monologue about muscle pain. Real talk: muscle symptoms are commonly reported in everyday practice, but large blinded randomized trials have found similar rates of muscle symptoms in placebo groupssuggesting expectation and misattribution (the “nocebo effect”) often play a role. That doesn’t mean side effects never happen; it means they’re frequently more manageable than the internet makes them sound.

5) The “asymptomatic = optional” trap

The study authors noted reasons that may drive non-treatment: difficulty accessing primary care, low screening rates, lack of consensus emphasis, and hesitance to treat people who feel fine. It’s a classic prevention paradox: prevention feels like doing homework for a test you might never take… until you do.

What “Getting Treated” Actually Means

Treatment isn’t automatically “take a pill forever.” It’s usually a staged plan based on your LDL level and overall risk:

Step 1: Confirm your numbers (and don’t stop at total cholesterol)

Ask for a lipid panel (LDL, HDL, triglycerides, and total cholesterol). Then ask one extra question: “What is my actual cardiovascular risk, and what LDL target makes sense for me?”

Step 2: Lifestyle changes that aren’t performative

Lifestyle can meaningfully improve cholesterolespecially if your LDL is mildly to moderately elevated. If your LDL is very high (especially ≥190), lifestyle is still important, but it’s often not enough on its own. Practical, evidence-aligned moves include:

• Replace saturated fat with unsaturated fats: The American Heart Association recommends limiting saturated fat (and avoiding trans fats). Translation: less butter/processed snacks, more nuts, seeds, fish, and plant oils.
• Increase soluble fiber: Think oats, beans, lentils, fruit (like apples/citrus), and veggies. Soluble fiber helps lower LDL by reducing how much cholesterol is absorbed.
• Move most days: Regular physical activity supports HDL (“good” cholesterol) and overall heart health.
• Quit smoking: Stopping smoking can raise HDL and improves cardiovascular risk in multiple ways.
• Sleep like it matters: NIH guidance highlights that good-quality sleep (often 7–9 hours for adults) is associated with healthier LDL/total cholesterol patterns.

A helpful mindset: choose 2–3 changes you can actually keep. The “perfect” plan you abandon in 10 days is not superior to the “pretty good” plan you do for 10 months.

Step 3: Medication when the risk math says “yes”

Medications are most often used when LDL is high enoughor your overall risk is high enoughthat lifestyle alone is unlikely to reduce risk sufficiently.

• Statins are typically first-line. They lower LDL by reducing cholesterol production in the liver and increasing the liver’s ability to remove LDL from the blood. Studies show they reduce the risk of heart attack and stroke in people who need them.
• Who is commonly considered? The USPSTF recommends statins for many adults ages 40–75 who have at least one risk factor (like dyslipidemia, diabetes, hypertension, or smoking) and a 10-year cardiovascular risk of 10% or more; and selective use for those with 7.5% to under 10% risk.
• Add-on options may be considered for certain high-risk patients if LDL remains above goal on maximally tolerated statins. These can include ezetimibe, PCSK9 inhibitors, and bile acid sequestrants (your clinician will match the option to your risk, goals, cost, and tolerance).

Safety note (the calm, boring kind): the FDA has stated that serious liver injury with statins is rare and unpredictable, and routine periodic liver enzyme monitoring isn’t generally needed. Testing is typically done before starting and then as clinically indicated.

The “Treatment Gap” Isn’t Just PersonalIt’s Structural

It’s tempting to frame cholesterol as an individual responsibility issue. But the study found higher unaware-and-untreated rates among people without insurance and those facing socioeconomic barriers. Add in appointment scarcity, transportation, time off work, and medication costs, and “just go to the doctor” starts to sound like “just grow wings.”

That’s why public health efforts like Million Hearts emphasize system-level fixes: better identification of patients who would benefit from statins, decision aids, shared decision-making, and improving follow-up so a single lab result doesn’t disappear into the void.

Don’t Miss Familial Hypercholesterolemia (FH)

FH is a genetic condition that can drive very high LDL starting early in life. The CDC notes that for many people with FH, lifestyle changes help but are often not enough; medication is usually needed. The encouraging part: finding and treating FH early can dramatically reduce coronary disease risk.

Clues that FH might be on the table include LDL ≥190 mg/dL (especially at a young age), strong family history of early heart disease, or multiple relatives with very high cholesterol. If that’s you, bring it up directly. “Could this be familial?” is a simple question with life-changing implications.

How to Talk to Your Clinician Without Leaving With Only Vibes

If you want a productive appointment, bring these questions (yes, literally on your phone):

1. What are my LDL, HDL, triglycerides, and non-HDL cholesterol numbers?
2. Given my overall risk, what LDL target makes sense for me?
3. Do I meet criteria for a statin based on guidelines and my 10-year risk?
4. What lifestyle change would give me the biggest LDL reduction for the effort?
5. If medication is recommended, what side effects should I actually watch for, and what’s the plan if I notice them?
6. When should we recheck labs to see whether the plan is working?

You’re not being “difficult.” You’re being the CEO of your own arteries.

Bottom Line

The U.S. has made progress in lowering average LDL levels over time, but the awareness-and-treatment gap remains stubborn: more than 4 in 10 adults with LDL in the 160–189 mg/dL range were still unaware and untreated in recent data. That gap is not evenly distributedyoung adults and underserved groups are hit harder. The fix is not one magic pill or one perfect diet. It’s a mix of smart screening, realistic lifestyle upgrades, appropriate medication when needed, and healthcare systems that make prevention easier than procrastination.

Medical note: This article is for informational purposes and does not replace personalized medical advice. Talk with a qualified clinician about your specific risk and treatment options.

Experiences From the “Untreated 40%” (Common Stories, Real Lessons)

People don’t usually wake up and choose “untreated high cholesterol.” What they chooseoften unknowinglyare the conditions that make untreated cholesterol more likely: fewer checkups, confusing advice, fear of medication, and a life schedule that treats self-care like an optional app update. Here are a few common experiences that show how the gap happens, and how people climb out of it.

Experience 1: “I felt fine, so I assumed I was fine.”

This is the classic. Someone in their 30s or 40s feels healthy, rarely gets sick, and assumes their heart is running the same “premium plan.” Then a routine lab (often triggered by a new job physical, a life insurance exam, or a spouse saying, “Please just go”) shows LDL around 165–180 mg/dL. The reaction is usually disbelieffollowed by a frantic week of Googling, a brief romance with kale, and a vow to “never eat cheese again,” which lasts until the next pizza night.

The lesson they learn: cholesterol isn’t a symptom-based condition. Feeling good doesn’t mean your LDL is behaving. The most effective next step isn’t panic; it’s a planrecheck timing, realistic dietary shifts, and a risk discussion that looks at the whole picture (blood pressure, family history, smoking, diabetes, and age).

Experience 2: “My doctor mentioned it once… and then it vanished.”

Another common story: a clinician says, “Your cholesterol is a bit high,” but the visit is rushed, the patient has three other problems to discuss, and the follow-up never gets scheduled. Months turn into years. The patient vaguely remembers a warning, but without a concrete target or next step, it becomes background noiselike that one smoke detector that chirps every 45 minutes and somehow never gets a new battery.

The lesson: if you leave without specifics, you’re likely to leave without progress. People who close the gap usually start by asking for exact numbers and a clear recheck date. Even better: they pick one measurable lifestyle change (like swapping saturated fats for unsaturated fats or adding soluble fiber daily) and track consistency rather than perfection.

Experience 3: “I was scared of statins because of what I heard online.”

Many people arrive at the medication conversation already primed to fear it. They’ve heard about muscle pain, memory issues, “toxins,” or that statins are “just a Band-Aid.” Sometimes they try supplements first, or they start a statin and stop after a few days because every normal ache suddenly feels suspicious. They don’t always tell their clinician; they just quietly ghost the prescription.

The lesson: the best outcomes often come from shared decision-making, not persuasion. People do better when they understand why a statin is recommended (risk reduction), what side effects actually warrant attention, and what alternatives or dose adjustments exist if intolerance occurs. A plan that includes “If you notice X, call us and we’ll troubleshoot” can turn fear into follow-through.

Experience 4: “My LDL was so high it didn’t make sense… until it did.”

This is the FH-flavored story. Someone sees an LDL ≥190 mg/dL and assumes the lab made a mistake. Or they’re young and athletic and can’t reconcile “I run 5Ks” with “my LDL is 210.” Then they learn about familial hypercholesterolemia, ask about family history, and suddenly the puzzle pieces snap together: a parent’s early heart attack, an uncle’s stents in his 50s, a grandparent who “had cholesterol problems forever.”

The lesson: extremely high LDL often needs medication early and consistently. For many, the emotional shift is huge: it’s not a moral failure or a willpower problemit’s biology. That reframing helps people commit to treatment without feeling like they’re “losing” to a pill.

Experience 5: “Small changes were boring… and that’s why they worked.”

The most sustainable success stories are rarely cinematic. They’re repetitive and mildly unglamorous: oatmeal or beans most days, fewer ultra-processed snacks, swapping butter-heavy habits for healthier fats, walking after dinner, consistent sleep, and actually picking up refills on time. People who lower LDL meaningfully often say the same thing: once the plan became routine, it stopped feeling like effort. It just became Tuesday.

The big takeaway from these experiences: closing the “untreated 40%” gap usually doesn’t require extreme anything. It requires clarity (know your numbers), continuity (recheck and follow up), and a plan that fits your real lifenot your fantasy life where you meal-prep 21 jars of chia pudding while doing hot yoga and smiling.